| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
deleted in lymphocytic leukemia 1 | 0.569 | 0.692 | 0.47 |
|
disease | 0.100 | None | 1.000 | 2 | 2 | 2011 | 2019 | ||||||||
|
long intergenic non-protein coding RNA 2580 | 0.931 | 0.192 |
|
disease | 0.100 | None | 1.000 | 2 | 2 | 2011 | 2011 | |||||||||
|
major histocompatibility complex, class I, F | 0.631 | 0.654 | 3.3E-05 |
|
disease | 0.100 | None | 1.000 | 2 | 5 | 2007 | 2009 | ||||||||
|
major histocompatibility complex, class II, DR beta 9 (pseudogene) | 0.682 | 0.654 |
|
disease | 0.100 | None | 1.000 | 2 | 6 | 2007 | 2010 | |||||||||
|
notch receptor 4 | 0.534 | 0.731 | 2.1E-23 |
|
disease | 0.130 | None | 1.000 | 2 | 3 | 2004 | 2013 | ||||||||
|
major histocompatibility complex, class II, DR alpha | 0.581 | 0.769 | 0.52 |
|
disease | 0.440 | None | 1.000 | 2 | 10 | 1999 | 2010 | ||||||||
|
methyltransferase like 1 | 0.931 | 0.154 | 2.0E-03 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2009 | 2019 | ||||||||
|
innate immunity activator | 0.743 | 0.346 | 2.2E-04 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2013 | ||||||||
|
Rho GTPase activating protein 31 | 0.581 | 0.615 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | ||||||||
|
IRF1 antisense RNA 1 | 0.670 | 0.385 | 4.2E-03 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | ||||||||
|
mannosidase beta | 0.736 | 0.462 | 1.3E-18 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | ||||||||
|
HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1 | 0.601 | 0.692 | 6.1E-06 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | ||||||||
|
PHD and ring finger domains 1 | 0.743 | 0.346 | 5.7E-02 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | ||||||||
|
bromodomain containing 2 | 0.450 | 0.808 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2007 | 2007 | ||||||||
|
ribonuclease L | 0.579 | 0.692 | 2.0E-10 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | ||||||||
|
epidermal growth factor receptor pathway substrate 15 like 1 | 0.743 | 0.385 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2013 | ||||||||
|
long intergenic non-protein coding RNA 243 | 0.729 | 0.423 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2007 | 2007 | |||||||||
|
Pvt1 oncogene | 0.495 | 0.731 |
|
disease | 0.110 | None | 0.667 | 1 | 2 | 2011 | 2017 | |||||||||
|
mitochondrial coiled-coil domain 1 | 0.890 | 0.231 | 1.9E-03 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2007 | 2007 | ||||||||
|
nuclear receptor coactivator 5 | 0.631 | 0.692 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2019 | ||||||||
|
LIM domain containing preferred translocation partner in lipoma | 0.543 | 0.769 | 7.2E-03 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2013 | ||||||||
|
protein tyrosine phosphatase non-receptor type 2 | 0.538 | 0.692 | 1.00 |
|
disease | 0.120 | None | 1.000 | 1 | 1 | 2011 | 2017 | ||||||||
|
mitogen-activated protein kinase 1 | 0.330 | 0.923 | 1.00 |
|
disease | 0.160 | None | 1.000 | 1 | 1 | 1999 | 2018 | ||||||||
|
Abelson helper integration site 1 | 0.513 | 0.846 | 1.1E-25 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2011 | 2018 | ||||||||
|
CDK5 regulatory subunit associated protein 1 like 1 | 0.617 | 0.615 | 1.6E-02 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 |